Team:Hong Kong HKUST/results

From 2013.igem.org

(Difference between revisions)
 
(25 intermediate revisions not shown)
Line 1: Line 1:
<html>
<html>
<head>
<head>
-
<script src="http://ajax.googleapis.com/ajax/libs/jquery/1.10.1/jquery.min.js">
+
<script src="http://ajax.googleapis.com/ajax/libs/jquery/1.10.2/jquery.min.js">
</script>
</script>
Line 29: Line 29:
});
});
</script>
</script>
-
 
-
 
<style type="text/css">
<style type="text/css">
-
div.menu
+
body{background-color:#494042;width:100%;margin-bottom:20px;min-width:600px;max-width:2000px;height:100%;}
-
{
+
#menubar
-
width:100%;
+
{background-color:#EEECEC;opacity:0.8;top:-4px;width:360px;height:23px;position:absolute;top:-20px;}
-
}
+
#menubar ul li a
-
 
+
{ color:#8D1919;}
 +
#menubar.right-menu
 +
{background-color:#EEECEC;opacity:0.8;top:-4px;width:240px;height:23px;position:absolute;top:-20px;}
 +
.right-menu li a
 +
{color:#8D1919;background-color:#EEECEC;}
 +
#p-logo
 +
{visibility:hidden;}
 +
.firstHeading
 +
{visibility:hidden;}
 +
#globalWrapper
 +
{position: relative;font-size:127%;width:100%;margin:0;padding:0;padding-bottom:10px;background-color:#494042;}
 +
#content
 +
{width: 1000px;border:none;background-color:#494042;padding:0px;margin-top:0px;line-height: 1.5em;color: black;}
 +
#top-section
 +
{height:2px;border:none;background-color:#494042;}
 +
#catlinks
 +
{border-color:#494042;background-color:#494042;}
 +
#footer-box
 +
{display:none}
 +
#kepala
 +
{position:absolute;top:15px;background-color:#F0A5BE;height:121px;width:100%;}
 +
#copyright
 +
{position:absolute;left:325px;top:630px;}
.menu ul,li
.menu ul,li
{
{
Line 44: Line 64:
width:100%;
width:100%;
}
}
-
 
-
 
-
 
ul.first>li
ul.first>li
{
{
float:left;
float:left;
-
width:16.5%;
+
width:16.66%;
}
}
ul.first>li>a:link,ul.first>li>a:visited
ul.first>li>a:link,ul.first>li>a:visited
Line 66: Line 83:
ul.first>li>a:hover,ul.first>li>a:active
ul.first>li>a:hover,ul.first>li>a:active
{
{
-
background-color:#7A991A;
+
background-color:#e32e51;
}
}
Line 89: Line 106:
ul.first>li>ul>li>a:hover,ul.first>li>ul>li>a:active
ul.first>li>ul>li>a:hover,ul.first>li>ul>li>a:active
{
{
-
background-color:#B26B00;
+
background-color:#f87790;
}
}
.menu
.menu
{
{
position:absolute;
position:absolute;
-
left:-8px;
+
left:0px;
-
top:140px;
+
top:141px;
 +
width:100%;
}
}
-
#banner
+
ul, ol {
-
{
+
line-height: 1.6;
-
position:absolute;
+
font-size: 14px;
-
left:-8px;
+
-
top:15px;
+
}
}
-
 
+
#slide{width:96%;height:auto;background-color:#F4DFC0;margin-top:80px;border:2px solid;
-
 
+
border-radius:15px;padding-right:10px;margin-left:15px;font-family:"Trebuchet MS",Helvetica,sans-serif;float:left;}
-
#copyright
+
#slide1{width:96%;height:auto;background-color:#F4DFC0;margin-top:20px;border:2px solid;
 +
border-radius:15px;padding-right:10px;margin-left:15px;font-family:"Trebuchet MS",Helvetica,sans-serif;float:left;}
 +
.center
{
{
-
position:absolute;
+
margin:auto;
-
right:320px;
+
width:70%;
-
top:700px;
+
background-color:#b0e0e6;
}
}
-
#globalWrapper
+
#interview,#presentation,#article, #interview1, #presentation1,#article1
-
{
+
{margin-top:20px;width:23%;margin-right:10px;float:left;height:230px; border:2px solid;
-
background-color:#b9b2a0;
+
border-radius:15px;font-family:"Trebuchet MS", Helvetica, sans-serif;}
-
height:800px;
+
#interview
-
}
+
{margin-left:0px;background:#e32e51;}
-
#content
+
#interview1
-
{
+
{margin-left:17px;background:#B0B0B0;}
-
background-color:#b9b2a0;
+
#presentation{background:#B0B0B0;}
-
border-color:#b9b2a0;
+
#article1
 +
{background:#35bb91;}
 +
#article,#presentation1
 +
{background:#e32e51;}
 +
#art-desc,#pre-desc,#int-desc{width:50%;float:right;margin-right:7px;}
 +
#art-img,#pre-img,#int-img{width:45%;float:left;margin-left:4px;}
 +
#art-desc-text,#pre-desc-text,#int-desc-text{float:right;}
 +
h3,h1,#yo{margin-left:10px;font-family:"Trebuchet MS", Helvetica, sans-serif;}
 +
h3.title{font-size:38px;}
-
}
+
#iGEM_Logo{
-
#menubar
+
width:100px;
-
{  
+
height:80px;
-
background-color:#EEECEC;
+
-
opacity:0.8;
+
-
top:-4px;
+
-
width:360px;
+
-
height:23px;
+
position:absolute;
position:absolute;
-
top:-20px;
+
right:10px;
 +
top:60px;
 +
z-index:+15;
}
}
-
#menubar ul li a
+
#hkust_Logo{
-
{  
+
width:60px;
-
color:#8D1919;
+
height:80px;
-
}
+
-
#menubar.right-menu
+
-
{
+
-
background-color:#EEECEC;
+
-
opacity:0.8;
+
-
top:-4px;
+
-
width:240px;
+
-
height:23px;
+
position:absolute;
position:absolute;
-
top:-20px;
+
right:110px;
-
}
+
top:60px;
-
.right-menu li a
+
z-index:+15;
-
{
+
-
color:#8D1919;
+
-
background-color:#EEECEC;
+
}
}
-
 
-
#p-logo
 
-
{
 
-
height:0px;
 
-
visibility:hidden;
 
-
}
 
-
#top-section
 
-
{
 
-
height:0px;
 
-
}
 
-
#footer-box
 
-
{
 
-
height:0px;
 
-
display:none;
 
-
visbility:hidden;
 
-
}
 
-
#catlinks
 
-
{
 
-
border-color:#b9b2a0;
 
-
background-color:#b9b2a0;
 
-
}
 
-
.firstHeading
 
-
{
 
-
visibility:hidden
 
-
}
 
-
 
</style>
</style>
-
 
</head>
</head>
 +
<body>
 +
 
 +
          <a href="https://2013.igem.org/Main_Page"><img id="iGEM_Logo" src="https://static.igem.org/mediawiki/2013/4/46/Igem_qgem_logo.png"></a>
 +
         
 +
<a href="http://www.ust.hk/eng/index.htm"><img id="hkust_Logo" src="https://static.igem.org/mediawiki/2013/5/55/Hkust_logo.gif"></a>
-
<body>
+
<a href=https://2013.igem.org/Team:Hong_Kong_HKUST><center><div id="kepala"><img src="https://static.igem.org/mediawiki/igem.org/c/c7/BANNER1_%281%29.png" style="height:121px;width:100%;"></div></center></a>
-
<h3><center><div style="height:121px;width:965px;"><img src="https://static.igem.org/mediawiki/2013/5/5a/Banner_gear.png" id="banner" style="height:121px;width:965px;align:middle;"></div></center></h3>
+
-
<div id="copyright">© Copyright HKUST iGEM Team 2013, All Rights Reserved<br><br><br></div>
 
<div class="menu">
<div class="menu">
<ul class="first">
<ul class="first">
Line 206: Line 194:
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/abstract">Abstract</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/abstract">Abstract</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/modules">Modules Description</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/modules">Modules Description</a></li>
 +
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/data">Data Page</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/Parts">Parts</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/Parts">Parts</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/characterization">Characterization</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/characterization">Characterization</a></li>
-
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/modelling">Modeling</a></li>
 
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/results">Result</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/results">Result</a></li>
 +
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/future">Future Work</a></li>
</ul>
</ul>
</li>
</li>
Line 218: Line 207:
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/protocols">Protocols</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/protocols">Protocols</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/safety">Safety</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/safety">Safety</a></li>
-
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/future">Future Work</a></li>
+
 
</ul>
</ul>
</li>
</li>
Line 231: Line 220:
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp">Human Practice</a>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp">Human Practice</a>
<ul>
<ul>
-
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/interview">Interviews</a></li>
 
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/cp">Country Profile</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/cp">Country Profile</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/blog">Blog</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/blog">Blog</a></li>
-
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/article">Article</a></li>
+
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/interview">Interviews</a></li>
 +
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/article/genet">Article</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/video">Videos</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/video">Videos</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/presentation">Presentations</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/presentation">Presentations</a></li>
Line 243: Line 232:
</div>
</div>
 +
<br><br><br>
 +
<div id="slide"><center><br><h3 class="title">Result</h3></center><br></div>
 +
<div id="interview1"><h3>Experiment 1: Glyoxylate Shunt</h3><div id="art-img"><br><img src="https://static.igem.org/mediawiki/2013/c/c0/Expt3.png" style="padding-left:5px;width:90%;padding-top:5px;"><center><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/experiment/exp4"><img src="http://w1ggroup.com/devere/img/more_off.png" style="width:80%;height:40px;padding-top:10px;"></a></center></div><div id="art-desc"><p id="art-desc-text"><br>Introduce glyoxylate enzymes responsible for the shunt</p></div></div>
 +
<div id="interview"><h3>Experiment 2: Protein Trafficking</h3><div id="pre-img"><br><img src="https://static.igem.org/mediawiki/2013/4/45/Expt2.png" style="padding-left:5px;width:105%;padding-top:8px;"><center><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/experiment/exp3"><br><img src="http://w1ggroup.com/devere/img/more_off.png" style="width:75%;height:40px;padding-top:2px;"></a></center></div><div id="pre-desc"><p id="pre-desc-text"><br>Target ACE proteins into mitochondria</p></div></div>
 +
<div id="presentation"><h3>Experiment 3: Fatty Acid Sensing Mechanism</h3><div id="pre-img"><br><img src="https://static.igem.org/mediawiki/2013/4/4f/Expt1.png" style="padding-left:5px;padding-top:5px;width:90%;"><center><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/experiment/exp2"><img src="http://w1ggroup.com/devere/img/more_off.png" style="width:80%;height:40px;padding-top:10px;"></a></center></div><div id="pre-desc"><p id="pre-desc-text"><br>Introduce inducible system that allows tunable fatty acid uptake by sensing fatty acid concentration</p></div></div>
-
</body>
+
<div id="article"><h3>Experiment 4: Cell Viability & Fatty Acid Quantification</h3><div id="pre-img"><br><img src="https://static.igem.org/mediawiki/2013/f/fa/Expt0.png" style="padding-left:2px;padding-top:5px;width:90%;"><center><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/experiment/exp1"><img src="http://w1ggroup.com/devere/img/more_off.png" style="width:80%;height:40px;padding-top:10px;"></a></center></div><div id="pre-desc"><br><p id="pre-desc-text">Measuring cell viability at different fatty acid concentration & measure fatty acid uptake rate</p></div></div>
 +
<div id="slide1">
 +
<p id="yo">Our project was first proposed in mid-March and after a series of improvement and elaboration, we started our wet lab work from mid-June to late-September. After 3 months of memorable diligent work, we are proud to claim that we have achieved the results below:
 +
<ul>
 +
  <li>Successfully constructed two parts</a> carrying mitochondrial leader sequence (MLS) compatible with RFC 10 and RFC 25 assembly standards respectively, (<a href="http://parts.igem.org/Part:BBa_K1119000">BBa_K1119000</a>, <a href="http://parts.igem.org/Part:BBa_K1119001">BBa_K1119001</a>).</li>
 +
  <li>Successfully constructed </a>parts containing the <i>aceA</i> and <i>aceB</i> elements of the glyoxylate shunt (<a href="http://parts.igem.org/Part:BBa_K1119002">BBa_K1119002</a>, <a href="http://parts.igem.org/Part:BBa_K1119003">BBa_K1119003</a>). </li>
 +
  <li>Successfully constructed a part containing the constitutive CMV promoter (<a href="http://parts.igem.org/Part:BBa_K1119006">BBa_K1119006</a>).</li>
 +
  <li>Successfully characterized the constitutive CMV promoter in HEK293FT cells (<a href="http://parts.igem.org/Part:BBa_K1119008">BBa_K1119008</a>).</li>
 +
<li>Successfully constructed a part containing the constitutive regulatory promoter of Human Elongation Factor 1-alpha (<a href="http://parts.igem.org/Part:BBa_K1119010">BBa_K1119010</a>).</li>
 +
<li>Successfully characterized the constitutive EF-1alpha promoter in HEK293FT cells (<a href="http://parts.igem.org/Part:BBa_K1119011">BBa_K1119011</a>).</li>
 +
  <li>Successfully characterized the mitochondrial leader sequence (MLS) in HEK293FT cells (<a href="http://parts.igem.org/Part:BBa_K1119009">BBa_K1119009</a>).</li>
 +
  <li>Successfully tested HepG2 cell viability in different sodium palmitate concentrations. </li>
 +
</ul></p>
 +
<br>
 +
</div>
 +
</body>
</html>
</html>

Latest revision as of 12:53, 28 October 2013





Result


Experiment 1: Glyoxylate Shunt



Introduce glyoxylate enzymes responsible for the shunt

Experiment 2: Protein Trafficking




Target ACE proteins into mitochondria

Experiment 3: Fatty Acid Sensing Mechanism



Introduce inducible system that allows tunable fatty acid uptake by sensing fatty acid concentration

Experiment 4: Cell Viability & Fatty Acid Quantification



Measuring cell viability at different fatty acid concentration & measure fatty acid uptake rate

Our project was first proposed in mid-March and after a series of improvement and elaboration, we started our wet lab work from mid-June to late-September. After 3 months of memorable diligent work, we are proud to claim that we have achieved the results below:

  • Successfully constructed two parts carrying mitochondrial leader sequence (MLS) compatible with RFC 10 and RFC 25 assembly standards respectively, (BBa_K1119000, BBa_K1119001).
  • Successfully constructed parts containing the aceA and aceB elements of the glyoxylate shunt (BBa_K1119002, BBa_K1119003).
  • Successfully constructed a part containing the constitutive CMV promoter (BBa_K1119006).
  • Successfully characterized the constitutive CMV promoter in HEK293FT cells (BBa_K1119008).
  • Successfully constructed a part containing the constitutive regulatory promoter of Human Elongation Factor 1-alpha (BBa_K1119010).
  • Successfully characterized the constitutive EF-1alpha promoter in HEK293FT cells (BBa_K1119011).
  • Successfully characterized the mitochondrial leader sequence (MLS) in HEK293FT cells (BBa_K1119009).
  • Successfully tested HepG2 cell viability in different sodium palmitate concentrations.


Retrieved from "http://2013.igem.org/Team:Hong_Kong_HKUST/results"